Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2003 1
2004 1
2007 1
2015 2
2016 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Cardiovascular Safety of Testosterone-Replacement Therapy.
Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Lincoff AM, et al. N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16. N Engl J Med. 2023. PMID: 37326322 Clinical Trial.
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Clinical Trial.
Measurement of the near-threshold e+e- --> D(*)+/-D(*)-/+ cross section using initial-state radiation.
Pakhlova G, Abe K, Adachi I, Aihara H, Anipko D, Aulchenko V, Aushev T, Bakich AM, Balagura V, Barberio E, Bay A, Bedny I, Belous K, Bitenc U, Bizjak I, Blyth S, Bondar A, Bozek A, Bracko M, Browder TE, Chang MC, Chao Y, Chen A, Chen KF, Chen WT, Cheon BG, Chistov R, Choi SK, Choi Y, Choi YK, Cole S, Dalseno J, Danilov M, Drutskoy A, Eidelman S, Fratina S, Gabyshev N, Gershon T, Gokhroo G, Golob B, Ha H, Haba J, Hayasaka K, Hayashii H, Hazumi M, Heffernan D, Hokuue T, Hoshi Y, Hou S, Hou WS, Iijima T, Ikado K, Imoto A, Inami K, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Kaji H, Kang JH, Kapusta P, Katayama N, Kawasaki T, Khan HR, Kichimi H, Kim YJ, Kinoshita K, Krizan P, Krokovny P, Kulasiri R, Kumar R, Kuo CC, Kuzmin A, Kwon YJ, Lee J, Lee MJ, Lee SE, Lesiak T, Lin SW, Liventsev D, Majumder G, Mandl F, Matsumoto T, Matyja A, McOnie S, Medvedeva T, Mitaroff W, Miyake H, Miyata H, Miyazaki Y, Mizuk R, Nakano E, Nakao M, Nakazawa H, Natkaniec Z, Nishida S, Nitoh O, Ogawa S, Ohshima T, Okuno S, Olsen SL, Onuki Y, Ozaki H, Pakhlov P, Park H, Park KS, Pestotnik R, Piilonen LE, Poluektov A, Sakai Y, Satoyama N, Schneider O, Schümann J, Schwartz AJ, Seidl R, Senyo K, Sevior ME, Shapkin M,… See abstract for full author list ➔ Pakhlova G, et al. Phys Rev Lett. 2007 Mar 2;98(9):092001. doi: 10.1103/PhysRevLett.98.092001. Epub 2007 Feb 27. Phys Rev Lett. 2007. PMID: 17359149 Free article.
We report a measurement of the exclusive e+e- -->D(*)+/-D*-/+ cross section as a function of center-of-mass energy near the D(*)+/-D*-/+ threshold with initial-state radiation. ...
We report a measurement of the exclusive e+e- -->D(*)+/-D*-/+ cross section as a function of center-of-mass energy near the …
Establishment of rat lymphatic endothelial cell line.
Mizuno R, Yokoyama Y, Ono N, Ikomi F, Ohhashi T. Mizuno R, et al. Microcirculation. 2003 Apr;10(2):127-31. doi: 10.1038/sj.mn.7800181. Microcirculation. 2003. PMID: 12700581
Factor VIII-related antigen and cell surface carbohydrates (i.e., D-galactose alpha and D-N-acetylgalactosamine alpha) were found on the lymphatic cultured cells. ...
Factor VIII-related antigen and cell surface carbohydrates (i.e., D-galactose alpha and D-N-acetylgalactosamine alpha) were fo …
Establishment of an animal model using recombinant NOD.B10.D2 mice to study initial adhesion of oral streptococci.
Abdus Salam M, Matsumoto N, Matin K, Tsuha Y, Nakao R, Hanada N, Senpuku H. Abdus Salam M, et al. Clin Diagn Lab Immunol. 2004 Mar;11(2):379-86. doi: 10.1128/cdli.11.2.379-386.2004. Clin Diagn Lab Immunol. 2004. PMID: 15013991 Free PMC article.
In nonobese diabetogenic (NOD) mice that spontaneously develop insulin-dependent diabetes mellitus (IDDM) and SS, we replaced major histocompatibility complex (MHC) class II (A(g7) E(g7)) and class I D(b) with MHC class II (A(d) E(d)) and class I D(d) from nondiabet …
In nonobese diabetogenic (NOD) mice that spontaneously develop insulin-dependent diabetes mellitus (IDDM) and SS, we replaced major histocom …
Growth and sporulation defects in Bacillus subtilis mutants with a single rrn operon can be suppressed by amplification of the rrn operon.
Yano K, Masuda K, Akanuma G, Wada T, Matsumoto T, Shiwa Y, Ishige T, Yoshikawa H, Niki H, Inaoka T, Kawamura F. Yano K, et al. Microbiology (Reading). 2016 Jan;162(1):35-45. doi: 10.1099/mic.0.000207. Epub 2015 Oct 30. Microbiology (Reading). 2016. PMID: 26518335 Free article.
We report here the isolation and characterization of suppressor mutants from seven strains that each have a single rrn operon (rrnO, A, J, I, E, D or B). The suppressor mutants for strain RIK656 with a single rrnO operon had a higher frequency of larger colonies. .. …
We report here the isolation and characterization of suppressor mutants from seven strains that each have a single rrn operon (rrnO, A, J, I …
Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes.
Takebayashi T, Iwamoto M, Jikko A, Matsumura T, Enomoto-Iwamoto M, Myoukai F, Koyama E, Yamaai T, Matsumoto K, Nakamura T, et al. Takebayashi T, et al. J Cell Biol. 1995 Jun;129(5):1411-9. doi: 10.1083/jcb.129.5.1411. J Cell Biol. 1995. PMID: 7775584 Free PMC article.
Recently the HGF receptor, c-met protooncogene product, has been shown to be expressed in developing limb buds (Sonnenberg, E., D. Meyer, M. Weidner, and C. Birchmeiyer, 1993. J. Cell Biol. 123: 223-235), suggesting that some populations of mesenchymal cells in limb …
Recently the HGF receptor, c-met protooncogene product, has been shown to be expressed in developing limb buds (Sonnenberg, E., D
Scalable two- and three-dimensional optical labels generated by 128-port encoder/decoder for optical packet switching.
Matsumoto R, Kodama T, Morita K, Wada N, Kitayama K. Matsumoto R, et al. Opt Express. 2015 Oct 5;23(20):25747-61. doi: 10.1364/OE.23.025747. Opt Express. 2015. PMID: 26480089 Free article.
In order to expand the system scalability of code label processing, we develop a record port count 128 x 128 optical encoder/decoder (E/D) and propose a novel three-dimensional (3-D) optical label combining code label with wavelength and polarization. ...
In order to expand the system scalability of code label processing, we develop a record port count 128 x 128 optical encoder/decoder (E